alexa

Search in Indianmoney's WealthPedia

 
Home News Lupin's US FDA compliance woes suggest the problem runs deeper

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Estate PlanningClick Here
 
 
Lupin's US FDA compliance woes suggest the problem runs deeper

Lupin's US FDA compliance woes suggest the problem runs deeper

Tuesday, January 14, 2020, 7:45 PM

There is no end in sight for India's third largest drug maker Lupin's regulatory woes. The company on January 13 said its Tarapur active pharmaceutical ingredient(API) manufacturing site in Maharashtra has been classified as official action indicated (OAI) by US FDA. The site was inspected by US FDA between September 16 and 20 last year, and issued three observations at the end of inspection.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

What is your Credit Score? Get FREE Credit Score in 1 Minute!

Get Start Now!
CIBIL Meter
Get It now!
Attention!

This is to inform that Suvision Holdings Pvt Ltd ("IndianMoney.com") do not charge any fees/security deposit/advances towards outsourcing any of its activities. All stake holders are cautioned against any such fraud.